Study in Adolescents With Schizophrenia or Bipolar Disorder
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
Open-label safety study of oral olanzapine treatment in adolescents, aged 13 to 17 years,
with bipolar I disorder (manic or mixed episodes) or schizophrenia.